The Golden State Warriors are facing challenges regarding the health of their new player Kristaps Porzingis. After acquiring him in a trade, the team had expected that Porzingis would contribute significantly with his height, defensive skills, and shooting accuracy, especially alongside star player Stephen Curry. However, Porzingis has only played one game since the trade due to illness, complicating expectations for his performance.

General Manager Mike Dunleavy expressed the severity of the situation on the TK Show, stating that based on medical evaluations, the team felt confident in moving forward with the trade. He pointed out the difficulty in discussing what was or wasn't disclosed concerning Porzingis' health prior to the trade. This lack of clarity leaves the Warriors in a tough spot as they rely on Porzingis to bolster their lineup.

The Warriors are scheduled to play against the Houston Rockets next Friday, and Porzingis will be traveling with the team despite his health complications. The situation raises questions about the effectiveness of pre-trade medical assessments and how such issues can impact team performance and player expectations in the high-stakes environment of the NBA.